# Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma

> **NCT05993429** · — · COMPLETED · sponsor: **Qilu Hospital of Shandong University** · enrollment: 200 (actual)

## Conditions studied

- Klatskin Tumor
- Cholangiocarcinoma
- Biopsy, Fine-Needle
- Endoscopic Retrograde Cholangiopancreatography

## Interventions

- **DIAGNOSTIC_TEST:** The sampling method selected in patients with suspected hilar cholangiocarcinoma

## Key facts

- **NCT ID:** NCT05993429
- **Lead sponsor:** Qilu Hospital of Shandong University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-14
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2026-01-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05993429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05993429, "Diagnostic Efficacy of EUS-FNA/B Versus ERCP With or Without POCS-TB in Patients With Suspected Hilar Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05993429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*